Needham & Company Maintains a 'Buy' on NuPathe (PATH); Zelrix Profile Continues to Grow Ahead of August FDA Action Date

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Needham & Company Maintains a 'Buy' on NuPathe (PATH); Zelrix Profile Continues to Grow Ahead of August FDA Action Date
NUPATHE (NYSE: PATH) Delayed: 16.01 -0.67 (4.02%)
Previous Close $16.68    52 Week High $4.49 
Open $16.66    52 Week Low $1.57 
Day High $16.82    P/E N/A 
Day Low $15.84    EPS $-2.31 
Volume 52,113,445